HCA
Income statement / Annual
Last year (2024), HCA Healthcare, Inc.'s total revenue was $70.60 B,
an increase of 8.67% from the previous year.
In 2024, HCA Healthcare, Inc.'s net income was $5.76 B.
See HCA Healthcare, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$70.60 B |
$64.97 B |
$60.23 B |
$58.75 B |
$51.53 B |
$51.34 B |
$46.68 B |
$43.61 B |
$41.49 B |
$39.68 B |
| Cost of Revenue |
$60.06 B
|
$55.34 B
|
$51.18 B
|
$49.07 B
|
$44.27 B
|
$43.62 B
|
$39.64 B
|
$37.09 B
|
$34.87 B
|
$33.42 B
|
| Gross Profit |
$10.55 B
|
$9.63 B
|
$9.05 B
|
$9.68 B
|
$7.26 B
|
$7.72 B
|
$7.04 B
|
$6.52 B
|
$6.62 B
|
$6.26 B
|
| Gross Profit Ratio |
0.15
|
0.15
|
0.15
|
0.16
|
0.14
|
0.15
|
0.15
|
0.15
|
0.16
|
0.16
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$31.17 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$31.17 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Other Expenses |
-$31.17 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$497.00 M
|
$447.00 M
|
$466.00 M
|
$430.00 M
|
$344.00 M
|
| Operating Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$497.00 M
|
$447.00 M
|
$466.00 M
|
$430.00 M
|
$344.00 M
|
| Cost And Expenses |
$60.06 B
|
$55.34 B
|
$51.18 B
|
$49.07 B
|
$44.27 B
|
$44.12 B
|
$40.08 B
|
$37.56 B
|
$35.30 B
|
$33.76 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$2.06 B
|
$1.94 B
|
$1.74 B
|
$1.53 B
|
$1.56 B
|
$1.84 B
|
$1.77 B
|
$1.67 B
|
$1.60 B
|
$1.54 B
|
| Depreciation & Amortization |
$3.31 B
|
$3.08 B
|
$2.97 B
|
$2.85 B
|
$2.72 B
|
$2.60 B
|
$2.28 B
|
$2.13 B
|
$1.97 B
|
$1.90 B
|
| EBITDA |
$13.90 B |
$12.72 B |
$13.29 B |
$14.22 B |
$9.71 B |
$9.68 B |
$9.38 B |
$8.18 B |
$8.37 B |
$7.40 B |
| EBITDA Ratio |
0.2
|
0.2
|
0.22
|
0.24
|
0.19
|
0.19
|
0.2
|
0.19
|
0.2
|
0.19
|
| Operating Income Ratio |
0.15
|
0.15
|
0.15
|
0.16
|
0.14
|
0.14
|
0.14
|
0.14
|
0.15
|
0.15
|
| Total Other Income/Expenses Net |
-$2.02 B
|
-$1.92 B
|
-$473.00 M
|
$155.00 M
|
-$1.83 B
|
-$1.97 B
|
-$1.26 B
|
-$1.68 B
|
-$1.38 B
|
-$1.96 B
|
| Income Before Tax |
$8.52 B
|
$7.71 B
|
$8.58 B
|
$9.83 B
|
$5.43 B
|
$5.24 B
|
$5.34 B
|
$4.38 B
|
$4.81 B
|
$3.96 B
|
| Income Before Tax Ratio |
0.12
|
0.12
|
0.14
|
0.17
|
0.11
|
0.1
|
0.11
|
0.1
|
0.12
|
0.1
|
| Income Tax Expense |
$1.87 B
|
$1.62 B
|
$1.75 B
|
$2.11 B
|
$1.04 B
|
$1.10 B
|
$946.00 M
|
$1.64 B
|
$1.38 B
|
$1.26 B
|
| Net Income |
$5.76 B
|
$5.24 B
|
$5.64 B
|
$6.96 B
|
$3.75 B
|
$3.51 B
|
$3.79 B
|
$2.22 B
|
$2.89 B
|
$2.13 B
|
| Net Income Ratio |
0.08
|
0.08
|
0.09
|
0.12
|
0.07
|
0.07
|
0.08
|
0.05
|
0.07
|
0.05
|
| EPS |
22.27 |
19.24 |
19.44 |
21.51 |
11.1 |
10.27 |
11.04 |
6.33 |
7.8 |
5.34 |
| EPS Diluted |
22 |
18.96 |
19.15 |
21.16 |
10.93 |
10.07 |
10.66 |
5.95 |
7.3 |
4.99 |
| Weighted Average Shares Out |
$258.60 M
|
$272.40 M
|
$290.35 M
|
$323.32 M
|
$338.27 M
|
$341.21 M
|
$342.90 M
|
$350.09 M
|
$370.54 M
|
$398.74 M
|
| Weighted Average Shares Out Diluted |
$261.81 M
|
$276.41 M
|
$294.67 M
|
$328.75 M
|
$343.61 M
|
$348.23 M
|
$355.30 M
|
$372.22 M
|
$395.85 M
|
$426.72 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
